DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Mahé I, Agnelli G, Ay C. et al.
Extended anticoagulant treatment with full- or reduced-dose apixaban in patients with cancer-associated venous thromboembolism: rationale and design of the API-CAT study.
Thromb Haemost 2022;
122 (04) 646-656
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.